Skip to Main Content

Author Details

Kiri A Sandler
Oregon Health and Science University
2012
26
12
PMIDPaper TitleJournal TitlePublished Year
34314814Development and Pilot Implementation of a Remote Monitoring System for Acute Toxicity Using Electronic Patient-Reported Outcomes for Patients Undergoing Radiation Therapy for Breast Cancer.Int J Radiat Oncol Biol Phys2021
30992160Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis.Eur Urol2020
31718822Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials.Eur Urol2020
31733382Comparison of Clinical Outcomes Stratified by Target Delineation for Patients Undergoing Stereotactic Body Radiotherapy for Spinal Metastases.World Neurosurg2020
30326032Association of Gleason Grade With Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-analysis.JAMA Oncol2019
30521167Dramatic polarization in genitourinary expert opinions regarding the clinical utility of positron emission tomography (PET) imaging in prostate cancer.Int Braz J Urol2019
30676300Is moderate hypofractionation accepted as a new standard of care in north america for prostate cancer patients treated with external beam radiotherapy? Survey of genitourinary expert radiation oncologists.Int Braz J Urol2019
30700319Serum erythropoietin levels, breast cancer and breast cancer-initiating cells.Breast Cancer Res2019
30332590Adjuvant vs. salvage radiation therapy in men with high-risk features after radical prostatectomy: Survey of North American genitourinary expert radiation oncologists.Can Urol Assoc J2019
29123013<sup>68</sup>Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning.J Nucl Med2018
30102201Content Validity of Anatomic Site-Specific Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Sets for Assessment of Acute Symptomatic Toxicities in Radiation Oncology.Int J Radiat Oncol Biol Phys2018
29976500Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study.Int J Radiat Oncol Biol Phys2018
29893274A Prospective Phase 2 Study Evaluating Safety and Efficacy of Combining Stereotactic Body Radiation Therapy With Heat-based Ablation for Centrally Located Lung Tumors.Int J Radiat Oncol Biol Phys2018
29509865Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.JAMA2018
29452837Dramatically Polarized Opinion on the Role of Brachytherapy Boost in Management of High-risk Prostate Cancer: A Survey of North American Genitourinary Expert Radiation Oncologists.Clin Genitourin Cancer2018
29174501Active Surveillance for Low and Intermediate Risk Prostate Cancer: Opinions of North American Genitourinary Oncology Expert Radiation Oncologists.Clin Genitourin Cancer2018
27870704Clinical Outcomes for Stereotactic Ablative Radiotherapy in Oligometastatic and Oligoprogressive Gynecological Malignancies.Int J Gynecol Cancer2017
28178376Treatment trends for patients with brain metastases: Does practice reflect the data?Cancer2017
29165282A Brief Opinion on Pulling Down Briefs.Int J Radiat Oncol Biol Phys2017
28721899Gaps in Radiation Therapy Awareness: Results From an Educational Multi-institutional Survey of US Internal Medicine Residents.Int J Radiat Oncol Biol Phys2017
27020109Feasibility and Initial Dosimetric Findings for a Randomized Trial Using Dose-Painted Multiparametric Magnetic Resonance Imaging-Defined Targets in Prostate Cancer.Int J Radiat Oncol Biol Phys2016
28740893Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinoma.Adv Radiat Oncol2016
25674540Multiparametric-MRI and Targeted Biopsies in the Management of Prostate Cancer Patients on Active Surveillance.Front Oncol2015
25963053Post-radiotherapy prostate biopsies reveal heightened apex positivity relative to other prostate regions sampled.Radiother Oncol2015
24674544Delineation and visualization of prostate cancer in multiparametric MRI.Pract Radiat Oncol2013
23326621Mapping Tumor Hypoxia In Vivo Using Pattern Recognition of Dynamic Contrast-enhanced MRI Data.Transl Oncol2012
  • 1 - 26 of 26

Recommended Authors

University of California los angeles
Career Start Year 2016
Number of shared co-authors 42
University of Michigan ann arbor
Career Start Year 2016
Number of shared co-authors 44
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 10
University of Michigan ann arbor
Career Start Year 2013
Number of shared co-authors 32
Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 3
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Career Start Year 2012
Number of shared co-authors 47
University of California los angeles
Career Start Year 2010
Number of shared co-authors 43
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 9
University of Washington
Career Start Year 2010
Number of shared co-authors 43
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 4
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 37
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 16
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 2006
Number of shared co-authors 36
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Career Start Year 2005
Number of shared co-authors 1
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 20
New York-Presbyterian Hospital, Weill Cornell Medical Center
Career Start Year 2005
Number of shared co-authors 9
University of Texas Southwestern Medical Center
Career Start Year 2004
Number of shared co-authors 15
University of Toronto, Princess Margaret Cancer Centre
Career Start Year 2004
Number of shared co-authors 37
University of California Los Angeles
Career Start Year 2003
Number of shared co-authors 46
Ghent University, GZA Ziekenhuizen
Career Start Year 2002
Number of shared co-authors 19
Abramson Cancer Center, University of Pennsylvania
Career Start Year 2001
Number of shared co-authors 19
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 3
University of California Los Angeles
Career Start Year 2000
Number of shared co-authors 10
Thomas Jefferson University Hospital
Career Start Year 1999
Number of shared co-authors 21
University of Chicago
Career Start Year 1997
Number of shared co-authors 26
Princess Margaret Hospital, University of Toronto
Career Start Year 1995
Number of shared co-authors 16
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 3
Huntsman Cancer Institute, University of Utah
Career Start Year 1994
Number of shared co-authors 35
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 31
University of California San Francisco
Career Start Year 1983
Number of shared co-authors 27

Collaborators

University of California los angeles
Co-authored papers 12
University of California los angeles
Co-authored papers 7
University of California los angeles
Co-authored papers 7
university of california los angeles Medical Center
Co-authored papers 6
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 6
David Geffen School of Medicine at university of california los angeles
Co-authored papers 5
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 5
Fox Chase Cancer Center
Co-authored papers 4
University of Miami Miller School of Medicine
Co-authored papers 4
University of Maryland School of Medicine
Co-authored papers 4
Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School
Co-authored papers 4
Cleveland Clinic
Co-authored papers 3
Urologic Research Institute, Ohio University School of Medicine
Co-authored papers 3
Duke University Medical Center
Co-authored papers 3
Cleveland Clinic
Co-authored papers 3
Urologic Research Institute, Ohio University School of Medicine
Co-authored papers 3
Johns Hopkins University School of Medicine
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Johns Hopkins University School of Medicine
Co-authored papers 3
Johns Hopkins University School of Medicine
Co-authored papers 3
Northwestern University
Co-authored papers 3
Ascension Providence Hospital
Co-authored papers 3
Vanderbilt University Medical Center
Co-authored papers 3
Johns Hopkins University School of Medicine
Co-authored papers 3
Oslo University Hospital
Co-authored papers 3
Johns Hopkins University
Co-authored papers 3
University of California los angeles
Co-authored papers 3
Oslo University Hospital
Co-authored papers 3
Cleveland Clinic
Co-authored papers 3
Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 3